| Literature DB >> 33324628 |
Wei-Hua Wang1,2, Fei Wang3, Hai-Feng Zhao4, Ke Yan1, Cui-Ling Huang5, Yin Yin6, Qiang Huang7, Zao-Zao Chen3,8, Wen-Yu Zhu1,2.
Abstract
Gelatin methacryloyl (GelMA) has been widely used in bone engineering. It can also be filled into the calvarial defects with irregular shape. However, lack of osteoinductive capacity limits its potential as a candidate repair material for calvarial defects. In this study, we developed an injectable magnesium-zinc alloy containing hydrogel complex (Mg-IHC), in which the alloy was fabricated in an atomization process and had small sphere, regular shape, and good fluidity. Mg-IHC can be injected and plastically shaped. After cross-linking, it contents the elastic modulus similar to GelMA, and has inner holes suitable for nutrient transportation. Furthermore, Mg-IHC showed promising biocompatibility according to our evaluations of its cell adhesion, growth status, and proliferating activity. The results of alkaline phosphatase (ALP) activity, ALP staining, alizarin red staining, and real-time polymerase chain reaction (PCR) further indicated that Mg-IHC could significantly promote the osteogenic differentiation of MC3T3-E1 cells and upregulate the genetic expression of collagen I (COL-I), osteocalcin (OCN), and runt-related transcription factor 2 (RUNX2). Finally, after applied to a mouse model of critical-sized calvarial defect, Mg-IHC remarkably enhanced bone formation at the defect site. All of these results suggest that Mg-IHC can promote bone regeneration and can be potentially considered as a candidate for calvarial defect repairing.Entities:
Keywords: bone regeneration; calvarial defect; gelatin methacryloyl; hydrogel; magnesium–zinc alloy
Year: 2020 PMID: 33324628 PMCID: PMC7726114 DOI: 10.3389/fbioe.2020.617585
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Sequences of primers used for real-time PCR.
| Genes | Primers | Sequences (5′-3′) |
| COL1 | Forward | GCTCCTCTTAGGGGCCACT |
| Reverse | CCACGTCTCACCATTGGGG | |
| OCN | Forward | CTTGAAGACCGCCTACAAAC |
| Reverse | GCTGCTGTGACATCCATAC | |
| RUNX2 | Forward | CCGTGGCCTTCAAGGTTGT |
| Reverse | TTCATAACAGCGGAGGCATTT | |
| β-actin | Forward | CTGACTGACTACCTC |
| Reverse | GACAGCGAGGCCAGGATG |
FIGURE 1Structure and mechanical properties of Mg-IHC. (A) Schematic illustrations of Mg-IHC formed after UV irradiation. (B) Schematic of Mg-IHC molding. (C) Elastic modulus of GelMA and Mg-IHC. (D) Degradation percentage of GelMA and Mg-IHC in vitro. (E) Scanning electron microscopy imaging of GelMA and Mg-IHC.
FIGURE 2In vitro biocompatibility test of Mg-IHC. (A) Magnesium ion concentration released by Mg-IHC in vitro was detected after 3, 7, 14, 21, and 28 days. (B) Cell viability detected by CCK-8 kit on 1, 3, and 7 days, respectively. (C) Statistics of the percentage of dead cells. Compare with Ctrl. **P < 0.01; ***P < 0.001. (D) Live/dead staining for MC3T3-E1 cells. The white arrows indicate dead cells. (E) Cell actin cytoskeleton staining showing the morphology of MC3T3-E1 cells on different substrate, stained with FITC-phalloidin.
FIGURE 3The effect of Mg-IHC on osteogenesis was examined in vitro. (A) MC3T3-E1 cells were cultured with GelMA and Mg-IHC extracts, and ALP was stained with ALP staining kit 7 days after osteogenesis induction, and calcium nodules were stained with alizarin red 14 days later. (B) Quantitative results of alizarin red staining. (C) MC3T3-E1 cells were cultured with GelMA and Mg-IHC extracts, and ALP activity was quantitatively detected using ALP activity kit 7 days after osteogenesis induction. (D–F) MC3T3-E1 cells were cultured with GelMA and Mg-IHC extracts, and 14 days after osteogenesis induction, the expression of osteogenesis-related genes COL-I, OCN, and RUNX2 was detected by real-time PCR. *P < 0.05; **P < 0.01; ***P < 0.001.
FIGURE 4Application of Mg-IHC to the repair of critical-sized calvarial defects in mice. (A) Schematic illustration of Mg-IHC for calvarial defects in mice. Four weeks after the use of Mg-IHC in mouse calvarial defects. (B) Schematic representation of micro-CT scan reconstruction. (C) Quantitative results of BV/TV. (D) Quantitative results of BMD. (E) Schematic diagram of H&E staining. (F) Schematic diagram of Masson staining. (G) Quantitative results of total neoplastic tissue at the defect site. (H) Quantitative results of mature bone at defect site. *P < 0.05; **P < 0.01; ***P < 0.001.